Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Return on Sales (2016 - 2025)

Fortress Biotech has reported Return on Sales over the past 13 years, most recently at 0.3% for Q4 2025.

  • Quarterly results put Return on Sales at 0.3% for Q4 2025, up 179.0% from a year ago — trailing twelve months through Dec 2025 was 0.83% (up 127.0% YoY), and the annual figure for FY2025 was 0.52%, up 167.0%.
  • Return on Sales for Q4 2025 was 0.3% at Fortress Biotech, down from 0.5% in the prior quarter.
  • Over the last five years, Return on Sales for FBIO hit a ceiling of 0.5% in Q3 2025 and a floor of 270.44% in Q2 2023.
  • Median Return on Sales over the past 5 years was 2.57% (2021), compared with a mean of 30.45%.
  • Biggest five-year swings in Return on Sales: tumbled -18244bps in 2023 and later surged 26861bps in 2024.
  • Fortress Biotech's Return on Sales stood at 3.56% in 2021, then crashed by -4331bps to 157.68% in 2022, then surged by 100bps to 0.72% in 2023, then plummeted by -192bps to 2.09% in 2024, then skyrocketed by 85bps to 0.3% in 2025.
  • The last three reported values for Return on Sales were 0.3% (Q4 2025), 0.5% (Q3 2025), and 2.18% (Q2 2025) per Business Quant data.